Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 12,172.00
Ask: 12,174.00
Change: 108.00 (0.90%)
Spread: 2.00 (0.016%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks turn red on return from Easter break

Tue, 02nd Apr 2024 15:22

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

The FTSE 100 ended the day down 0.22% at 7,935.09, while the FTSE 250 fell 0.86% to finish at 19,713.89.

In currency markets, sterling was last up 0.16% on the dollar to trade at $1.2572, while it declined 0.05% against the euro, changing hands at €1.1677.

"The UK stock market continued where it left off before the Easter break and briefly made a new 14-month high above the 8,000 mark despite disappointing UK house price data before ending the day flat," said IG senior market analyst Axel Rudolph.

"Other European stock indices were trading lower, in line with their US counterparts, despite German inflation dropping to a near three-year low and euro area inflation expectations hitting a two-year low.

"Monday's stronger-than-expected US ISM factory activity and a rebound in new orders for manufacturing goods in Europe and the US led to US yields nearing three-month highs."

Rudolph said they did so amid worries that inflation could return, provoking a sell-off in equities following their strong first-quarter rally.

"While the gold price hit a new record high on Tuesday, with the silver price playing catch up and nearing its December and March peaks, the oil price remains on track for its fourth straight day of gains amid heightened geopolitical tensions in the Middle East."

Manufacturing sector expands, house price growth slows

In economic news, the UK manufacturing sector saw a welcome expansion last month, marking the first growth since July 2022.

According to a closely-followed survey by S&P Global, the purchasing managers' index (PMI) for the manufacturing sector climbed from 47.5 in February to 50.3 in March.

The uptick, surpassing economists' expectations of a stagnant reading at 49.9, signified a shift towards growth.

While subindices such as new orders and output showed improvement, concerns lingered as employment and stocks of purchases continued to decline, albeit at slower rates compared to the previous month.

"Potential blockers remain such as continued weak export performance and supply chain stresses, with the neighbouring EU market the main drag on overseas demand and the Red Sea crisis still impacting supply chains," said S&P Global Market Intelligence director Rob Dobson.

"Signs from the survey that the impact of both of these factors is easing is therefore welcome news."

In contrast, the UK housing market experienced an unexpected slowdown in house price inflation.

According to data from lender Nationwide, house prices recorded a slight month-on-month decrease of 0.2% in March, following a 0.7% increase in February.

On an annual basis, prices rose 1.6%, falling short of the consensus forecast of 2.4%.

Regional disparities were evident, with Northern Ireland leading in price gains while the South West witnessed a decline.

"The small fall in the Nationwide house price index in March follows two strong months, so it's just a blip," said Pantheon Macroeconomics chief UK economist Rob Wood.

"We continue to expect house prices to rise 4% year-over-year in 2024, broadly in line with the current trend pace of increase in the main house price indices but a little weaker than the rise in nominal wages we expect as affordability is stretched."

On the continent, eurozone manufacturing activity faced headwinds in March as demand dwindled.

The final HCOB eurozone manufacturing PMI slipped to 46.1 from February's 46.5, indicating contraction for the month.

Despite that, there was a slight uptick in the PMI output index, hinting at a modest improvement in output levels.

Across the Atlantic, the US labour market showed signs of stability, with job openings remaining largely unchanged in February.

According to the Department of Labor, the number of job openings increased marginally by 0.1% from the prior month to reach 8.756 million.

Hiring also saw a modest uptick, while the quits rate and total separations remained relatively stable.

Commodities lift miners and oil plays, consumer stocks slip

On London's equity markets, mining and oil stocks were buoyed by an uptick in commodity prices.

Fresnillo led the risers with a gain of 7.58%, followed by Anglo American, up 4.6%; Rio Tinto, ahead 1.99%; Glencore, which added 3.01%; BP, advancing 2.74%; Antofagasta, which grew 1.32%; and Shell, which closed 3.22% firmer.

Elsewhere, HSBC Holdings saw a modest rise of 0.39% after completing the sale of its Canadian banking operations to RBC.

The move was expected to unlock significant value, with the company expecting to recognize a gain on sale of $4.9bn in the first quarter of 2024.

On the downside, consumer goods companies faced headwinds, with Reckitt Benckiser Group down 4.15%, Coca-Cola HBC off 2.2%, and Ocado Group closing 4.22% weaker.

Housebuilders also struggled, with Persimmon off 3.5% and Taylor Wimpey losing 3.06%, and builders' merchant CRH sliding 2.4% on the back of the weak housing price data.

Real estate developers Land Securities Group, Segro, Hammerson and Unite Group also found themselves in the red, losing 0.33%, 0.35%, 3.53% and 3.27%, respectively.

Biopharma giant AstraZeneca slipped 0.69% despite receiving approval from US regulators for its Voydeva drug.

Meanwhile, Ithaca Energy slumped 7.97% following last week's reports of potential tie-ups with Italy's Eni and disappointing annual profits blamed on government energy taxes.

Additionally, Mobico Group continued its downward trend, losing 5.39% a week after issuing a profit warning and facing delays in its annual results due to auditing issues.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,935.09 -0.22%

FTSE 250 (MCX) 19,713.89 -0.86%

techMARK (TASX) 4,478.92 -1.28%

FTSE 100 - Risers

Fresnillo (FRES) 504.00p 7.58%

Anglo American (AAL) 2,041.50p 4.60%

Shell (SHEL) 2,717.00p 3.50%

Glencore (GLEN) 448.40p 3.01%

BP (BP.) 508.60p 2.60%

Convatec Group (CTEC) 293.40p 2.44%

Rio Tinto (RIO) 5,117.00p 1.99%

Antofagasta (ANTO) 2,066.00p 1.32%

United Utilities Group (UU.) 1,041.00p 1.17%

Beazley (BEZ) 673.00p 1.13%

FTSE 100 - Fallers

Reckitt Benckiser Group (RKT) 4,275.00p -5.25%

Entain (ENT) 757.60p -4.99%

Ocado Group (OCDO) 435.90p -4.22%

Persimmon (PSN) 1,270.00p -3.50%

Burberry Group (BRBY) 1,171.50p -3.42%

Unite Group (UTG) 946.00p -3.27%

M&G (MNG) 213.30p -3.27%

Bunzl (BNZL) 2,950.00p -3.22%

Land Securities Group (LAND) 637.50p -3.14%

Scottish Mortgage Inv Trust (SMT) 867.60p -3.13%

FTSE 250 - Risers

AO World (AO.) 104.20p 3.37%

Kainos Group (KNOS) 994.00p 2.95%

TI Fluid Systems (TIFS) 148.20p 2.92%

Fidelity China Special Situations (FCSS) 206.50p 2.74%

Dr. Martens (DOCS) 90.05p 2.62%

Petershill Partners (PHLL) 194.00p 2.54%

Renishaw (RSW) 4,350.00p 2.35%

Bakkavor Group (BAKK) 110.50p 2.31%

BlackRock World Mining Trust (BRWM) 529.00p 2.13%

Diversified Energy Company (DEC) 967.50p 2.06%

FTSE 250 - Fallers

Ithaca Energy (ITH) 122.40p -7.97%

Mobico Group (MCG) 64.50p -7.33%

Tritax Eurobox (GBP) (EBOX) 50.90p -6.26%

Carnival (CCL) 1,102.50p -5.73%

Watches of Switzerland Group (WOSG) 340.80p -4.96%

Aston Martin Lagonda Global Holdings (AML) 161.80p -4.77%

Trustpilot Group (TRST) 189.40p -4.73%

Marshalls (MSLH) 263.00p -4.29%

Oxford Instruments (OXIG) 2,040.00p -4.00%

Close Brothers Group (CBG) 402.20p -3.83%

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.